Oxybutynin Chloride Tablet, Extended Release
NDC Package 67046-1599-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Oxybutynin Chloride tablets is oxybutynin is used to treat certain bladder and urinary conditions (e.g., overactive bladder). This formulation utilizes a tablet, extended release delivery system. Marketed by Coupler Llc, this product is identified by NDC 67046-1599 and is authorized under FDA application ANDA211655.

Identification & Billing

NDC Package Code
67046-1599-3
Package Description
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
67046-1599
11-Digit Billing Format
67046159903
RxNorm Crosswalk
  • RxCUI: 863636 - oxyBUTYnin chloride 5 MG 24HR Extended Release Oral Tablet
  • RxCUI: 863636 - 24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet
  • RxCUI: 863636 - oxybutynin chloride 5 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Oxybutynin Chloride
Non-Proprietary Name
Oxybutynin Chloride
Substance Name
Oxybutynin Chloride
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
OXYBUTYNIN CHLORIDE 5 mg/1
Pharmacologic Class
Usage Information
Oxybutynin is used to treat certain bladder and urinary conditions (e.g., overactive bladder). It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. The manufacturer does not recommend using this medication in children younger than 5 years of age.

Regulatory & Marketing

Labeler Name
Coupler Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA211655
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-23-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67046-1599-3 identifies a specific commercial package of 30 tablet, extended release in 1 blister pack of Oxybutynin Chloride, a human prescription drug labeled by Coupler Llc. This tablet, extended release is formulated for oral use and contains oxybutynin chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Coupler Llc on September 23, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Oxybutynin is used to treat certain bladder and urinary conditions (e.g., overactive bladder). It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. The manufacturer does not recommend using this medication in children younger than 5 years of age.

How is this Coupler Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67046159903. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67046-1599-3
11-Digit CMS (5-4-2)
67046-1599-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.